Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 18/06/20041 min de leitura
Notice of Approval of Abbreviated New Animal Drug Application; Dexamethasone Sodium Phosphate Injection
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration's Center for Veterinary Medicine (CVM) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by Cross Vetpharm Group Ltd. The ANADA provides for the veterinary prescription use of dexamethasone sodium phosphate injectable solution as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses. The applicable sections of the regulations did not require amendment.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →